HHT most commonly involves mutations of two genes: endoglin (ENG, on chromosome 9, HHT1) or activin A receptor type II-like 1 (ACVRL1/ALK1, on chromosome 12, HHT2). The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.